CL Colgate-Palmolive Company
Colgate-Palmolive Company (CL) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $2.3M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Wallace Noel R. | Chairman, President & CEO | Sell | 20,000 | $100.26 | $2.0M | 359,700 −5.3% of holding | |
| NORRINGTON LORRIE M | Director | Sell | 4,170 | $99.31 | $414.1K | 43,383 −8.8% of holding | |
| Hazlin John | Chief Growth Officer | Sell | 23,376 | $99.15 | $2.3M | 27,021 −46.4% of holding | |
| Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | Sell | 19,938 | $98.74 | $2.0M | 9,111 −68.6% of holding | |
| Tsourapas Panagiotis | COO, CD, EMEA, APac, Skin | Sell | 10,000 | $92.05 | $920.5K | 64,901 −13.4% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.